The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | 78,301 |
| Depreciation and amortization | 27,712 |
| Amortization of debt discount | 1,221 |
| Non-cash operating lease expense | 6,596 |
| Unrealized (gain) loss on investments in equity securities | 1,506 |
| Realized loss on available-for-sale investments | -2,209 |
| Gain on divested business | 116,953 |
| Stock-based compensation expense | 11,032 |
| Loss on disposal of property and equipment | -1,012 |
| Change in credit losses | 304 |
| Excess and obsolete inventory | 393 |
| Change in contingent consideration | -5,207 |
| Accounts receivable | 6,527 |
| Inventories | 2,185 |
| Prepaid expenses and other current assets | -1,353 |
| Deposits | 189 |
| Operating lease liabilities | -5,036 |
| Accounts payable and other accrued expenses | -3,464 |
| Accrued compensation and related expenses | 1,909 |
| Deferred revenue | -216 |
| Net deferred tax liability | 661 |
| Net cash used in operating activities | -8,580 |
| Purchases of property and equipment | 16,439 |
| Software development costs | 1,832 |
| Proceeds from divested business | 210,239 |
| Sales/maturities of short-term investments | 59,589 |
| Patent and trademark costs | 1,234 |
| Net cash provided by investing activities | 250,323 |
| Proceeds from exercise of stock options | 3,972 |
| Repurchase of common stock | 10,011 |
| Repayment of convertible senior notes | 14,344 |
| Repayment of notes payable | -161 |
| Repayment of finance lease liabilities | 530 |
| Net cash used in financing activities | -21,074 |
| Effect of exchange rates on cash and cash equivalents | -15,464 |
| Net change in cash and cash equivalents | 205,205 |
| Cash and cash equivalents - beginning of period | 45,289 |
| Cash and cash equivalents - end of period | 250,494 |
Cryoport, Inc. (CYRX)
Cryoport, Inc. (CYRX)